BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
102:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
diverse predilection for site and degree of :@0.084242:0.484360:0.480486:0.484360:0.480486:0.468604:0.084242:0.468604:0.013181:0.003848:0.010660:0.012508:0.005792:0.007466:0.012508:0.005369:0.013123:0.005715:0.012508:0.013181:0.003848:0.003848:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005369:0.006042:0.012604:0.005792:0.005359:0.007466:0.003848:0.006523:0.012508:0.005369:0.013143:0.011738:0.013181:0.005369:0.013181:0.012508:0.012950:0.005709:0.012508:0.012508:0.005369:0.012604:0.006042:0.005330
disease expression. :@0.084242:0.499944:0.266570:0.499944:0.266570:0.484188:0.084242:0.484188:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.012508:0.009236:0.013123:0.005721:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330
Moreover, they display  vastly  disparate :@0.084242:0.531125:0.480467:0.531125:0.480467:0.515369:0.084242:0.515369:0.017684:0.012604:0.005707:0.012508:0.012604:0.010660:0.012508:0.003764:0.005330:0.012700:0.006523:0.011738:0.012508:0.010314:0.012700:0.013181:0.003848:0.007466:0.013123:0.003848:0.013143:0.010314:0.005330:0.007395:0.010660:0.013143:0.007466:0.006523:0.003848:0.010314:0.005330:0.007383:0.013181:0.003848:0.007466:0.013123:0.013143:0.005792:0.013143:0.006523:0.012508:0.005330
behaviour clinically, which is why it is most :@0.084242:0.546709:0.480490:0.546709:0.480490:0.530953:0.084242:0.530953:0.013123:0.012508:0.011738:0.013143:0.010660:0.003848:0.012604:0.011699:0.005792:0.005661:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.005677:0.015990:0.011738:0.003848:0.012450:0.011738:0.005663:0.003848:0.007466:0.005677:0.015990:0.011738:0.010314:0.005665:0.003848:0.006523:0.005667:0.003848:0.007466:0.005677:0.018049:0.012604:0.007466:0.006523:0.005330
useful, from a clinical and treatment point :@0.084242:0.562293:0.480476:0.562293:0.480476:0.546537:0.084242:0.546537:0.011699:0.007466:0.012508:0.006042:0.011699:0.003848:0.005330:0.005407:0.006042:0.005713:0.012604:0.018049:0.005407:0.013143:0.005407:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005426:0.013143:0.011738:0.013181:0.005407:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005407:0.013123:0.012604:0.003848:0.011738:0.006523:0.005330
of view, to approach lymphoma based :@0.084242:0.577877:0.480463:0.577877:0.480463:0.562121:0.084242:0.562121:0.012604:0.006042:0.009891:0.010660:0.003848:0.012508:0.015990:0.005330:0.009891:0.006523:0.012604:0.009891:0.013143:0.013123:0.013123:0.005715:0.012604:0.013143:0.012450:0.011738:0.009891:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.009891:0.013123:0.013143:0.007466:0.012508:0.013181:0.005330
on  three  clinical presentation  patterns :@0.084242:0.593461:0.480478:0.593461:0.480478:0.577705:0.084242:0.577705:0.012604:0.011738:0.005330:0.009104:0.006523:0.011738:0.005707:0.012508:0.012508:0.005330:0.009107:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.014451:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.009106:0.013123:0.013143:0.006523:0.006523:0.012508:0.006188:0.011738:0.007466:0.005330
(see Table 2).:@0.084242:0.609045:0.207394:0.609045:0.207394:0.593289:0.084242:0.593289:0.007100:0.007466:0.012508:0.012508:0.005330:0.007197:0.013143:0.013123:0.003848:0.012508:0.005330:0.010660:0.007100:0.005330
15:@0.207401:0.603460:0.219831:0.603460:0.219831:0.594275:0.207401:0.594275:0.006215:0.006215
n   :@0.084242:0.621550:0.107051:0.621550:0.107051:0.613110:0.084242:0.613110:0.009762:0.003566:0.005914:0.003566
The low-grade or indolent lymphoma :@0.103485:0.624669:0.454235:0.624669:0.454235:0.608913:0.103485:0.608913:0.008197:0.011738:0.012508:0.005330:0.003848:0.012604:0.015990:0.006388:0.012950:0.005792:0.013143:0.013181:0.012508:0.005330:0.012604:0.005792:0.005330:0.003848:0.011738:0.013181:0.012604:0.003848:0.012508:0.011738:0.006523:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330
group:@0.103485:0.640253:0.159571:0.640253:0.159571:0.624497:0.103485:0.624497:0.012950:0.005709:0.012604:0.011699:0.013123
n   :@0.084242:0.652730:0.107051:0.652730:0.107051:0.644290:0.084242:0.644290:0.009762:0.003566:0.005914:0.003566
The high-grade or aggressive :@0.103485:0.655849:0.379053:0.655849:0.379053:0.640093:0.103485:0.640093:0.008197:0.011738:0.012508:0.005330:0.011738:0.003848:0.012950:0.011738:0.006388:0.012950:0.005792:0.013143:0.013181:0.012508:0.005330:0.012604:0.005792:0.005330:0.013143:0.012950:0.012950:0.005675:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.005330
lymphoma group:@0.103485:0.671433:0.265771:0.671433:0.265771:0.655677:0.103485:0.655677:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.012950:0.005711:0.012604:0.011699:0.013123
n   :@0.084242:0.683910:0.107051:0.683910:0.107051:0.675470:0.084242:0.675470:0.009762:0.003566:0.005914:0.003566
The very high-grade or very aggressive :@0.103485:0.687029:0.468255:0.687029:0.468255:0.671273:0.103485:0.671273:0.008197:0.011738:0.012508:0.005330:0.010660:0.012508:0.005792:0.010314:0.005330:0.011738:0.003848:0.012950:0.011738:0.006388:0.012950:0.005792:0.013143:0.013181:0.012508:0.005330:0.012604:0.005792:0.005330:0.010660:0.012508:0.005792:0.010314:0.005330:0.013143:0.012950:0.012950:0.005669:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.005330
lymphoma group:@0.103485:0.702613:0.265771:0.702613:0.265771:0.686857:0.103485:0.686857:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.012950:0.005711:0.012604:0.011699:0.013123
Certain upfront characteristics predict the :@0.084242:0.733794:0.480497:0.733794:0.480497:0.718038:0.084242:0.718038:0.015452:0.012315:0.005600:0.006331:0.012950:0.003656:0.011545:0.007087:0.011507:0.012931:0.005850:0.005519:0.012411:0.011545:0.006331:0.007087:0.012257:0.011545:0.012950:0.005600:0.012950:0.012257:0.006331:0.012315:0.005600:0.003656:0.007274:0.006331:0.003656:0.012257:0.007274:0.007087:0.012931:0.005521:0.012315:0.012989:0.003656:0.012257:0.006331:0.007087:0.006331:0.011545:0.012506:0.005330
grade of aggressiveness of the lymphoma. :@0.084242:0.749378:0.480474:0.749378:0.480474:0.733622:0.084242:0.733622:0.012758:0.005600:0.012950:0.012989:0.012315:0.005446:0.012411:0.005850:0.005446:0.012950:0.012758:0.012758:0.005519:0.012315:0.007274:0.007274:0.003656:0.010468:0.012315:0.011545:0.012315:0.007274:0.007274:0.005446:0.012411:0.005850:0.005446:0.006331:0.011545:0.012315:0.005446:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.005326:0.005330
Making the correct subtype diagnosis is :@0.084242:0.764962:0.480522:0.764962:0.480522:0.749206:0.084242:0.749206:0.017491:0.012950:0.009467:0.003656:0.011545:0.012758:0.011430:0.006331:0.011545:0.012315:0.011430:0.012257:0.012411:0.005600:0.005521:0.012315:0.012257:0.006331:0.011430:0.007274:0.011507:0.012931:0.006331:0.010122:0.012931:0.012315:0.011430:0.012989:0.003656:0.012950:0.012758:0.011545:0.012411:0.007274:0.003656:0.007274:0.011430:0.003656:0.007470:0.005330
becoming increasingly important, as treat-:@0.084242:0.780546:0.475158:0.780546:0.475158:0.764790:0.084242:0.764790:0.012931:0.012315:0.012257:0.012411:0.017857:0.003656:0.011545:0.012758:0.005780:0.003656:0.011545:0.012257:0.005519:0.012315:0.012950:0.007274:0.003656:0.011545:0.012758:0.003656:0.010122:0.005780:0.003656:0.017857:0.012931:0.012411:0.005600:0.006331:0.012950:0.011545:0.006331:0.005138:0.005780:0.012950:0.007274:0.005780:0.006331:0.005521:0.012315:0.012950:0.006331:0.006388
ment for lymphoma is becoming progres-:@0.084242:0.796130:0.475165:0.796130:0.475165:0.780374:0.084242:0.780374:0.017857:0.012315:0.011545:0.006331:0.007582:0.005850:0.012411:0.005600:0.007582:0.003656:0.010122:0.017857:0.012931:0.011545:0.012411:0.017857:0.012950:0.007582:0.003656:0.007274:0.007582:0.012931:0.012315:0.012257:0.012411:0.017857:0.003656:0.011545:0.012758:0.007582:0.012931:0.005521:0.012411:0.012758:0.005519:0.012315:0.007274:0.006388
sively more tailored to subtype. Once the :@0.084242:0.811714:0.480455:0.811714:0.480455:0.795958:0.084242:0.795958:0.007274:0.003656:0.010468:0.012315:0.003656:0.010122:0.007524:0.017857:0.012411:0.005519:0.012315:0.007524:0.006331:0.012950:0.003656:0.003656:0.012411:0.005521:0.012315:0.012989:0.007524:0.006331:0.012411:0.007524:0.007274:0.011507:0.012931:0.006331:0.010122:0.012931:0.012315:0.005138:0.007524:0.016529:0.011545:0.012257:0.012315:0.007524:0.006331:0.011545:0.012506:0.005330
diagnostic subtype is known, treatment :@0.084242:0.827298:0.480517:0.827298:0.480517:0.811542:0.084242:0.811542:0.012989:0.003656:0.012950:0.012758:0.011545:0.012411:0.007274:0.006331:0.003656:0.012257:0.013297:0.007274:0.011507:0.012931:0.006331:0.010122:0.012931:0.012315:0.013297:0.003656:0.007274:0.013297:0.009467:0.011545:0.012411:0.015798:0.011545:0.005138:0.013297:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006521:0.005330
can be approached within the framework :@0.084242:0.842882:0.480480:0.842882:0.480480:0.827126:0.084242:0.827126:0.012257:0.012950:0.011545:0.005869:0.012931:0.012315:0.005869:0.012950:0.012931:0.012931:0.005521:0.012411:0.012950:0.012257:0.011545:0.012315:0.012989:0.005869:0.015798:0.003656:0.006331:0.011545:0.003656:0.011545:0.005869:0.006331:0.011545:0.012315:0.005869:0.005850:0.005600:0.012950:0.017857:0.012315:0.015798:0.012411:0.005600:0.009660:0.005330
of one of these three clinical groups.:@0.084242:0.858466:0.417036:0.858466:0.417036:0.842710:0.084242:0.842710:0.012411:0.005850:0.005138:0.012411:0.011545:0.012315:0.005138:0.012411:0.005850:0.005138:0.006331:0.011545:0.012315:0.007274:0.012315:0.005138:0.006331:0.011545:0.005521:0.012315:0.012315:0.005138:0.012257:0.003656:0.003656:0.011545:0.003656:0.012257:0.012950:0.003656:0.005138:0.012758:0.005521:0.012411:0.011507:0.012931:0.007274:0.005330
Lymphoma is treated with classic chem-:@0.102426:0.874050:0.475154:0.874050:0.475154:0.858294:0.102426:0.858294:0.008447:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005186:0.003848:0.007466:0.005195:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.005184:0.015990:0.003848:0.006523:0.011738:0.005186:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.012450:0.005195:0.012450:0.011738:0.012508:0.018049:0.006388
otherapeutic  agents and new targeted :@0.084242:0.889634:0.480499:0.889634:0.480499:0.873878:0.084242:0.873878:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.005330:0.005334:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.010680:0.013143:0.011738:0.013181:0.010680:0.011738:0.012508:0.015990:0.010680:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.012508:0.013181:0.005330
biological therapies.:@0.084242:0.905218:0.273819:0.905218:0.273819:0.889462:0.084242:0.889462:0.013123:0.003848:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.007466:0.005330
Depending on the tumour type, treat-:@0.102426:0.920802:0.475169:0.920802:0.475169:0.905046:0.102426:0.905046:0.013932:0.012123:0.012738:0.012123:0.011353:0.012796:0.003464:0.011353:0.012565:0.011661:0.012219:0.011353:0.011661:0.006138:0.011353:0.012123:0.011661:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.011661:0.006138:0.009929:0.012738:0.012123:0.004945:0.011661:0.006138:0.005328:0.012123:0.012758:0.006138:0.006388
ment is typically delivered in cycles, with or :@0.084242:0.936386:0.480457:0.936386:0.480457:0.920630:0.084242:0.920630:0.017665:0.012123:0.011353:0.006138:0.006225:0.003464:0.007081:0.006223:0.006138:0.009929:0.012738:0.003464:0.012065:0.012758:0.003464:0.003464:0.009929:0.006225:0.012796:0.012123:0.003464:0.003464:0.010275:0.012123:0.005328:0.012123:0.012796:0.006223:0.003464:0.011353:0.006223:0.012065:0.009929:0.012065:0.003464:0.012123:0.007081:0.004945:0.006225:0.015606:0.003464:0.006138:0.011353:0.006223:0.012219:0.005786:0.005330
without radiotherapy, scheduled to recur at :@0.523643:0.484279:0.919894:0.484279:0.919894:0.468523:0.523643:0.468523:0.015606:0.003464:0.006138:0.011353:0.012219:0.011315:0.006138:0.004734:0.005407:0.012758:0.012796:0.003464:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.004945:0.004734:0.007081:0.012065:0.011353:0.012123:0.012796:0.011315:0.003464:0.012123:0.012796:0.004734:0.006138:0.012219:0.004734:0.005326:0.012123:0.012065:0.011315:0.005407:0.004734:0.012758:0.006519:0.005330
two- to four-week intervals. Patients are hos-:@0.523643:0.500167:0.914581:0.500167:0.914581:0.484411:0.523643:0.484411:0.006138:0.015606:0.012219:0.006004:0.004762:0.006138:0.012219:0.004761:0.005657:0.012219:0.011315:0.005407:0.006004:0.015606:0.012123:0.012123:0.009275:0.004762:0.003464:0.011353:0.006138:0.012123:0.005407:0.010275:0.012758:0.003464:0.007081:0.004945:0.004761:0.011007:0.012758:0.006138:0.003464:0.012123:0.011353:0.006138:0.007081:0.004761:0.012758:0.005326:0.012123:0.004762:0.011353:0.012219:0.007081:0.006388
pitalised for high-risk or aggressive disease, :@0.523643:0.516055:0.919898:0.516055:0.919898:0.500299:0.523643:0.500299:0.012738:0.003464:0.006138:0.012758:0.003464:0.003464:0.007081:0.012123:0.012796:0.007582:0.005657:0.012219:0.005407:0.007582:0.011353:0.003464:0.012565:0.011353:0.006004:0.005407:0.003464:0.007081:0.009275:0.007582:0.012219:0.005407:0.007582:0.012758:0.012565:0.012565:0.005328:0.012123:0.007081:0.007081:0.003464:0.010275:0.012123:0.007582:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.005328:0.005330
but mostly treatment is on an out-patient :@0.523643:0.531944:0.919954:0.531944:0.919954:0.516188:0.523643:0.516188:0.012738:0.011315:0.006138:0.009256:0.017665:0.012219:0.007081:0.006138:0.003464:0.009929:0.009256:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.009256:0.003464:0.007081:0.009256:0.012219:0.011353:0.009256:0.012758:0.011353:0.009256:0.012219:0.011315:0.006138:0.006004:0.012738:0.012758:0.006138:0.003464:0.012123:0.011353:0.006519:0.005330
basis. Chemotherapy combinations are :@0.523643:0.547832:0.919898:0.547832:0.919898:0.532076:0.523643:0.532076:0.012738:0.012758:0.007081:0.003464:0.007081:0.004945:0.016895:0.015259:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.016895:0.012065:0.012219:0.017665:0.012738:0.003464:0.011353:0.012758:0.006138:0.003464:0.012219:0.011353:0.007081:0.016895:0.012758:0.005328:0.012506:0.005330
used and, increasingly, biological therapy is :@0.523643:0.563720:0.919903:0.563720:0.919903:0.547964:0.523643:0.547964:0.011315:0.007081:0.012123:0.012796:0.005215:0.012758:0.011353:0.012796:0.004945:0.005215:0.003464:0.011353:0.012065:0.005328:0.012123:0.012758:0.007081:0.003464:0.011353:0.012565:0.003464:0.009929:0.004945:0.005215:0.012738:0.003464:0.012219:0.003464:0.012219:0.012565:0.003464:0.012065:0.012758:0.003464:0.005215:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.005215:0.003464:0.007470:0.005330
added (see Tables 3 and 4). The most well-:@0.523643:0.579608:0.914514:0.579608:0.914514:0.563852:0.523643:0.563852:0.012758:0.012796:0.012796:0.012123:0.012796:0.006254:0.006716:0.007081:0.012123:0.012123:0.006254:0.006812:0.012758:0.012738:0.003464:0.012123:0.007081:0.006254:0.010275:0.006254:0.012758:0.011353:0.012796:0.006254:0.010275:0.006716:0.004945:0.006254:0.007812:0.011353:0.012123:0.006254:0.017665:0.012219:0.007081:0.006138:0.006254:0.015606:0.012123:0.003464:0.003464:0.006388
known biological drug in lymphoma and :@0.523643:0.595496:0.919884:0.595496:0.919884:0.579741:0.523643:0.579741:0.009275:0.011353:0.012219:0.015606:0.011353:0.010141:0.012738:0.003464:0.012219:0.003464:0.012219:0.012565:0.003464:0.012065:0.012758:0.003464:0.010141:0.012796:0.005407:0.011315:0.012565:0.010141:0.003464:0.011353:0.010141:0.003464:0.009929:0.017665:0.012738:0.011353:0.012219:0.017665:0.012758:0.010141:0.012758:0.011353:0.013183:0.005330
the  first  among  anti-tumour  cell  antibody :@0.523643:0.611385:0.919913:0.611385:0.919913:0.595629:0.523643:0.595629:0.006138:0.011353:0.012123:0.005330:0.004766:0.004493:0.004493:0.005407:0.007081:0.006138:0.005330:0.004766:0.012758:0.017665:0.012219:0.011353:0.012565:0.005330:0.004766:0.012758:0.011353:0.006138:0.003464:0.006004:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.005330:0.004766:0.012065:0.012123:0.003464:0.003464:0.005330:0.004766:0.012758:0.011353:0.006138:0.003464:0.012738:0.012219:0.012796:0.010316:0.005330
therapy  in  any  tumour  type,  is  rituximab, :@0.523643:0.627273:0.919890:0.627273:0.919890:0.611517:0.523643:0.611517:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.005330:0.005338:0.003464:0.011353:0.005330:0.005338:0.012758:0.011353:0.009929:0.005330:0.005338:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.005330:0.005338:0.006138:0.009929:0.012738:0.012123:0.004945:0.005330:0.005340:0.003464:0.007081:0.005330:0.005340:0.005407:0.003464:0.006138:0.011315:0.008852:0.003464:0.017665:0.012758:0.012738:0.005326:0.005330
an anti-CD20 humanised monoclonal anti-:@0.523643:0.643161:0.914552:0.643161:0.914552:0.627405:0.523643:0.627405:0.012758:0.011353:0.007139:0.012758:0.011353:0.006138:0.003464:0.006004:0.015259:0.013932:0.010275:0.010275:0.007139:0.011353:0.011315:0.017665:0.012758:0.011353:0.003464:0.007081:0.012123:0.012796:0.007139:0.017665:0.012219:0.011353:0.012219:0.012065:0.003464:0.012219:0.011353:0.012758:0.003464:0.007139:0.012758:0.011353:0.006138:0.003464:0.006388
body therapy. Nevertheless, the backbone :@0.523643:0.659049:0.919905:0.659049:0.919905:0.643293:0.523643:0.643293:0.012738:0.012219:0.012796:0.009929:0.006125:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.004945:0.006125:0.013855:0.012123:0.010275:0.012123:0.005407:0.006138:0.011353:0.012123:0.003464:0.012123:0.007081:0.007081:0.004945:0.006125:0.006138:0.011353:0.012123:0.006127:0.012738:0.012758:0.012065:0.009275:0.012738:0.012219:0.011353:0.012506:0.005330
of most initial chemotherapy schedules for :@0.523643:0.674938:0.919907:0.674938:0.919907:0.659182:0.523643:0.659182:0.012219:0.005657:0.007379:0.017665:0.012219:0.007081:0.006138:0.007389:0.003464:0.011353:0.003464:0.006138:0.003464:0.012758:0.003464:0.007379:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.007379:0.007081:0.012065:0.011353:0.012123:0.012796:0.011315:0.003464:0.012123:0.007081:0.007389:0.005657:0.012219:0.005788:0.005330
lymphoma remains corticosteroid therapy. :@0.523643:0.690826:0.919913:0.690826:0.919913:0.675070:0.523643:0.675070:0.003464:0.009929:0.017665:0.012738:0.011353:0.012219:0.017665:0.012758:0.008293:0.005328:0.012123:0.017665:0.012758:0.003464:0.011353:0.007081:0.008293:0.012065:0.012219:0.005407:0.006138:0.003464:0.012065:0.012219:0.007081:0.006138:0.012123:0.005328:0.012219:0.003464:0.012796:0.008293:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.005326:0.005330
Increasingly, the malignant activation path-:@0.523643:0.706714:0.914569:0.706714:0.914569:0.690958:0.523643:0.690958:0.003964:0.011353:0.012065:0.005328:0.012123:0.012758:0.007081:0.003464:0.011353:0.012565:0.003464:0.009929:0.004945:0.004849:0.006138:0.011353:0.012123:0.004849:0.017665:0.012758:0.003464:0.003464:0.012565:0.011353:0.012758:0.011353:0.006138:0.004849:0.012758:0.012065:0.006138:0.003464:0.010275:0.012758:0.006138:0.003464:0.012219:0.011353:0.004849:0.012738:0.012758:0.006138:0.011353:0.006388
ways in lymphoma growth are being tar-:@0.523643:0.722602:0.914548:0.722602:0.914548:0.706846:0.523643:0.706846:0.015606:0.012758:0.009929:0.007081:0.009429:0.003464:0.011353:0.009429:0.003464:0.009929:0.017665:0.012738:0.011353:0.012219:0.017665:0.012758:0.009429:0.012565:0.005328:0.012219:0.015606:0.006138:0.011353:0.009429:0.012758:0.005328:0.012123:0.009429:0.012738:0.012123:0.003464:0.011353:0.012565:0.009429:0.006138:0.012758:0.005407:0.006388
geted by novel biological drugs, of which a :@0.523643:0.738491:0.919903:0.738491:0.919903:0.722735:0.523643:0.722735:0.012565:0.012123:0.006138:0.012123:0.012796:0.005099:0.012738:0.009929:0.005099:0.011353:0.012219:0.010275:0.012123:0.003464:0.005099:0.012738:0.003464:0.012219:0.003464:0.012219:0.012565:0.003464:0.012065:0.012758:0.003464:0.005099:0.012796:0.005407:0.011315:0.012565:0.007081:0.004945:0.005099:0.012219:0.005657:0.005099:0.015606:0.011353:0.003464:0.012065:0.011353:0.005099:0.013144:0.005330
few examples are given, denoted by an *. :@0.523643:0.754379:0.919878:0.754379:0.919878:0.738623:0.523643:0.738623:0.005657:0.012123:0.015606:0.006619:0.012123:0.008852:0.012758:0.017665:0.012738:0.003464:0.012123:0.007081:0.006619:0.012758:0.005328:0.012123:0.006619:0.012565:0.003464:0.010275:0.012123:0.011353:0.004945:0.006619:0.012796:0.012123:0.011353:0.012219:0.006138:0.012123:0.012796:0.006619:0.012738:0.009929:0.006619:0.012758:0.011353:0.006619:0.007793:0.005328:0.005330
These drugs are novel in action and hold the :@0.523643:0.770267:0.919903:0.770267:0.919903:0.754511:0.523643:0.754511:0.007812:0.011353:0.012123:0.007081:0.012123:0.004012:0.012796:0.005407:0.011315:0.012565:0.007081:0.004010:0.012758:0.005328:0.012123:0.004010:0.011353:0.012219:0.010275:0.012123:0.003464:0.004010:0.003464:0.011353:0.004010:0.012758:0.012065:0.006138:0.003464:0.012219:0.011353:0.004010:0.012758:0.011353:0.012796:0.004010:0.011353:0.012219:0.003464:0.012796:0.004010:0.006138:0.011353:0.012506:0.005330
promise of revolutionising lymphoma thera-:@0.523643:0.786155:0.914548:0.786155:0.914548:0.770399:0.523643:0.770399:0.012738:0.005328:0.012219:0.017665:0.003464:0.007081:0.012123:0.006158:0.012219:0.005657:0.006158:0.005328:0.012123:0.010275:0.012219:0.003464:0.011315:0.006138:0.003464:0.012219:0.011353:0.003464:0.007081:0.003464:0.011353:0.012565:0.006158:0.003464:0.009929:0.017665:0.012738:0.011353:0.012219:0.017665:0.012758:0.006158:0.006138:0.011353:0.012123:0.005407:0.012758:0.006388
py, but this comes at a prohibitive price.:@0.523643:0.802784:0.881338:0.802784:0.881338:0.787028:0.523643:0.787028:0.012738:0.009929:0.004945:0.004945:0.012738:0.011315:0.006138:0.004945:0.006138:0.011353:0.003464:0.007081:0.004945:0.012065:0.012219:0.017665:0.012123:0.007081:0.004945:0.012758:0.006138:0.004945:0.012758:0.004945:0.012738:0.005328:0.012219:0.011353:0.003464:0.012738:0.003464:0.006138:0.003464:0.010275:0.012123:0.004945:0.012738:0.005407:0.003464:0.012065:0.012123:0.005330
EARLY DIAGNOSIS OF LYMPHOMA :@0.523636:0.845162:0.911221:0.845162:0.911221:0.825565:0.523636:0.825565:0.012230:0.017404:0.013641:0.010348:0.014581:0.006585:0.016463:0.006585:0.017404:0.019756:0.017404:0.019756:0.012230:0.006585:0.012230:0.006585:0.019756:0.011289:0.006585:0.010348:0.014581:0.021167:0.013170:0.015993:0.019756:0.021167:0.017404:0.006585
AND REFERRAL: FUTURE  :@0.523636:0.864726:0.789371:0.864726:0.789371:0.845130:0.523636:0.845130:0.017404:0.017404:0.016463:0.006585:0.013641:0.012230:0.011289:0.012230:0.013641:0.013641:0.017404:0.010348:0.006585:0.006585:0.011289:0.015052:0.009878:0.015052:0.013641:0.012230:0.006562:0.006585
DIRECTIONS:@0.523636:0.884291:0.656751:0.884291:0.656751:0.864694:0.523636:0.864694:0.016463:0.006585:0.013641:0.012230:0.018344:0.009878:0.006585:0.019756:0.017404:0.012230
Lymphoma is high on the list of differential :@0.523636:0.903214:0.919902:0.903214:0.919902:0.887458:0.523636:0.887458:0.008447:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005638:0.003848:0.007466:0.005638:0.011738:0.003848:0.012950:0.011738:0.005638:0.012604:0.011738:0.005623:0.006523:0.011738:0.012508:0.005625:0.003848:0.003848:0.007466:0.006523:0.005638:0.012604:0.006042:0.005638:0.013181:0.003848:0.006102:0.006042:0.012508:0.005711:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.005330
diagnoses of many commonly occurring :@0.523636:0.919843:0.919900:0.919843:0.919900:0.904088:0.523636:0.904088:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.007466:0.008794:0.012604:0.006042:0.008794:0.018049:0.013143:0.011738:0.010314:0.008794:0.012450:0.012604:0.018049:0.018049:0.012604:0.011724:0.003848:0.010314:0.008794:0.012604:0.012450:0.012450:0.011699:0.005792:0.005792:0.003848:0.011738:0.012950:0.005330
clinical syndromes. Its incidence increases :@0.523636:0.936473:0.919877:0.936473:0.919877:0.920717:0.523636:0.920717:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005484:0.007466:0.010314:0.011738:0.013181:0.005719:0.012604:0.018049:0.012508:0.007466:0.005330:0.005474:0.004349:0.006523:0.007466:0.005484:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005474:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.007466:0.005330
Non-Hodgkin’s lymphoma: T- and NK-cell neoplasms:@0.093868:0.111116:0.578969:0.111116:0.578969:0.095083:0.093868:0.095083:0.014047:0.012123:0.011353:0.007889:0.012892:0.012123:0.012508:0.012508:0.010968:0.004426:0.011353:0.005195:0.008274:0.005195:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012508:0.005195:0.005195:0.007889:0.007889:0.005195:0.012508:0.011353:0.012508:0.005195:0.014047:0.011738:0.007889:0.012123:0.012123:0.004426:0.004426:0.005195:0.011353:0.012123:0.012123:0.012508:0.004426:0.012508:0.008274:0.017895:0.008467
Precursor  :@0.093868:0.133540:0.188925:0.133540:0.188925:0.117506:0.093868:0.117506:0.010583:0.005965:0.012123:0.012123:0.011353:0.005965:0.008274:0.012123:0.006154:0.005007:0.005388
T-cell neoplasm:@0.093868:0.149706:0.239340:0.149706:0.239340:0.133672:0.093868:0.133672:0.007889:0.007889:0.012123:0.012123:0.004426:0.004426:0.005195:0.011353:0.012123:0.012123:0.012508:0.004426:0.012508:0.008274:0.018088
Precursor T-lymphoblastic lymphoma/leukaemia:@0.296163:0.133540:0.742779:0.133540:0.742779:0.117506:0.296163:0.117506:0.010583:0.005965:0.012123:0.012123:0.011353:0.005965:0.008274:0.012123:0.005965:0.005195:0.007889:0.007889:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.012508:0.004426:0.012508:0.008274:0.005580:0.004426:0.012123:0.005195:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012508:0.008659:0.004426:0.012123:0.011353:0.010968:0.012508:0.012123:0.017895:0.004426:0.012700
Post-transplant lymphoproliferative disorders:@0.093868:0.172129:0.503494:0.172129:0.503494:0.156373:0.093868:0.156373:0.011392:0.012604:0.007466:0.006523:0.006388:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.013123:0.005707:0.012604:0.003848:0.003848:0.006042:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.013181:0.003848:0.007466:0.012604:0.005678:0.013181:0.012508:0.005792:0.007466
Majority :@0.093868:0.194553:0.173012:0.194553:0.173012:0.178797:0.093868:0.178797:0.017684:0.013143:0.003906:0.012604:0.005792:0.003848:0.006523:0.010314:0.005330
mature :@0.173012:0.194553:0.246056:0.194553:0.246056:0.178797:0.173012:0.178797:0.018049:0.013143:0.006523:0.011699:0.005792:0.012508:0.005330
B-cell:@0.093868:0.210719:0.143956:0.210719:0.143956:0.194963:0.093868:0.194963:0.011045:0.006388:0.012450:0.012508:0.003848:0.003848
 neoplasm- :@0.143956:0.210719:0.253483:0.210719:0.253483:0.194963:0.143956:0.194963:0.005330:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.006388:0.005330
seldom:@0.093868:0.226885:0.161524:0.226885:0.161524:0.211129:0.093868:0.211129:0.007466:0.012508:0.003848:0.013181:0.012604:0.018049
T-/NK-cell:@0.093868:0.243051:0.181517:0.243051:0.181517:0.227295:0.093868:0.227295:0.008197:0.006388:0.008409:0.014239:0.011372:0.006388:0.012450:0.012508:0.003848:0.003848
n:@0.296155:0.191432:0.305917:0.191432:0.305917:0.182992:0.296155:0.182992:0.009762
   Plasmacytic hyperplasia PTLD:@0.305920:0.194551:0.600593:0.194551:0.600593:0.178795:0.305920:0.178795:0.005330:0.015207:0.000000:0.011392:0.003848:0.013143:0.007466:0.018049:0.013143:0.012450:0.010314:0.006523:0.003848:0.012463:0.005330:0.011738:0.010314:0.013123:0.012508:0.005792:0.013123:0.003848:0.013143:0.007466:0.003848:0.013143:0.005330:0.011392:0.008197:0.008890:0.014316
n:@0.296155:0.207454:0.305917:0.207454:0.305917:0.199014:0.296155:0.199014:0.009762
   Infectious mononucleosis PTLD:@0.305920:0.210573:0.607732:0.210573:0.607732:0.194817:0.305920:0.194817:0.005330:0.015207:0.000000:0.004349:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011699:0.007466:0.005330:0.018040:0.012604:0.011738:0.012604:0.011738:0.011699:0.012450:0.003848:0.012508:0.012604:0.007466:0.003848:0.007466:0.005330:0.011376:0.008197:0.008890:0.014316
n:@0.296155:0.223476:0.305917:0.223476:0.305917:0.215036:0.296155:0.215036:0.009762
   Florid follicular hyperplasia PTLD:@0.305920:0.226595:0.619027:0.226595:0.619027:0.210839:0.305920:0.210839:0.005330:0.015207:0.000000:0.009333:0.003848:0.012604:0.005792:0.003848:0.013181:0.005330:0.006042:0.012604:0.003848:0.003848:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330:0.011738:0.010314:0.013123:0.012508:0.005792:0.013123:0.003848:0.013143:0.007466:0.003848:0.013156:0.005330:0.011392:0.008197:0.008890:0.014316
n:@0.296155:0.239498:0.305917:0.239498:0.305917:0.231058:0.296155:0.231058:0.009762
   Polymorphic PTLD:@0.305920:0.242617:0.490343:0.242617:0.490343:0.226861:0.305920:0.226861:0.005330:0.015207:0.000000:0.011392:0.012604:0.003848:0.010314:0.018049:0.012604:0.005792:0.013123:0.011738:0.003848:0.012450:0.005328:0.011392:0.008197:0.008890:0.014316
n:@0.296155:0.255520:0.305917:0.255520:0.305917:0.247080:0.296155:0.247080:0.009762
   Monomorphic PTLD (B- and T-/NK-cell types:@0.305920:0.258639:0.728291:0.258639:0.728291:0.242883:0.305920:0.242883:0.005330:0.015207:0.000000:0.017684:0.012604:0.011738:0.012604:0.018049:0.012604:0.005792:0.013123:0.011719:0.003848:0.012450:0.005330:0.011392:0.008197:0.008890:0.014316:0.005330:0.007100:0.011045:0.006388:0.005330:0.013143:0.011738:0.013181:0.005330:0.008197:0.006388:0.008409:0.014239:0.011372:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.006523:0.010314:0.013123:0.012508:0.007466
n:@0.296155:0.271542:0.305917:0.271542:0.305917:0.263102:0.296155:0.263102:0.009762
    Classical Hodgkin’s lymphoma PTLD:@0.305920:0.274661:0.658324:0.274661:0.658324:0.258905:0.305920:0.258905:0.005330:0.015207:0.000000:0.000000:0.015644:0.003848:0.013143:0.007466:0.007466:0.003848:0.012450:0.013143:0.003848:0.005330:0.013143:0.012621:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.011392:0.008197:0.008890:0.014316
Histiocytic and dendritic cell neoplasms:@0.093869:0.297084:0.461938:0.297084:0.461938:0.281329:0.093869:0.281329:0.013143:0.003848:0.007466:0.006523:0.003848:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330:0.013143:0.011738:0.013181:0.005330:0.013181:0.012508:0.011738:0.013181:0.005792:0.003848:0.006523:0.003848:0.012450:0.005330:0.012450:0.012508:0.003848:0.003848:0.005330:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049:0.007466
Histiocyte and :@0.093869:0.321479:0.231818:0.321479:0.231818:0.305723:0.093869:0.305723:0.013143:0.003848:0.007466:0.006523:0.003848:0.012604:0.012450:0.010314:0.006523:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330
dendritic cell-type:@0.093869:0.337645:0.270168:0.337645:0.270168:0.321889:0.093869:0.321889:0.013181:0.012508:0.011738:0.013181:0.005792:0.003848:0.006523:0.003848:0.012450:0.011719:0.012450:0.012508:0.003848:0.003848:0.006388:0.006523:0.010314:0.013123:0.012508
- :@0.176938:0.337645:0.188657:0.337645:0.188657:0.321889:0.176938:0.321889:0.006388:0.005330
 :@0.270168:0.337645:0.275498:0.337645:0.275498:0.321889:0.270168:0.321889:0.005330
neoplasm:@0.093869:0.353811:0.186348:0.353811:0.186348:0.338055:0.093869:0.338055:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.018049
n:@0.296155:0.318364:0.305917:0.318364:0.305917:0.309924:0.296155:0.309924:0.009762
   Histiocytic sarcoma:@0.305920:0.321483:0.507321:0.321483:0.507321:0.305727:0.305920:0.305727:0.005330:0.015207:0.000000:0.013143:0.003848:0.007466:0.006523:0.003848:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005334:0.007466:0.013143:0.005657:0.012450:0.012604:0.018049:0.013143
n:@0.296155:0.334386:0.305917:0.334386:0.305917:0.325946:0.296155:0.325946:0.009762
   Langerhans-cell histiocytosis:@0.305920:0.337505:0.587183:0.337505:0.587183:0.321749:0.305920:0.321749:0.005330:0.015207:0.000000:0.008890:0.013143:0.011738:0.012950:0.012508:0.006337:0.011738:0.013143:0.011738:0.007466:0.006388:0.012450:0.012508:0.003848:0.003848:0.005334:0.011738:0.003848:0.007466:0.006523:0.003848:0.012604:0.012450:0.010314:0.006523:0.012604:0.007466:0.003848:0.007466
n:@0.296155:0.350408:0.305917:0.350408:0.305917:0.341968:0.296155:0.341968:0.009762
   Langerhans-cell sarcoma:@0.305920:0.353527:0.562999:0.353527:0.562999:0.337771:0.305920:0.337771:0.005330:0.015207:0.000000:0.008890:0.013143:0.011738:0.012950:0.012508:0.006337:0.011738:0.013143:0.011738:0.007466:0.006388:0.012450:0.012508:0.003848:0.003848:0.005334:0.007466:0.013143:0.005661:0.012450:0.012604:0.018049:0.013143
n:@0.296155:0.366430:0.305917:0.366430:0.305917:0.357990:0.296155:0.357990:0.009762
   Indeterminate dendritic cell tumour:@0.305920:0.369549:0.657450:0.369549:0.657450:0.353793:0.305920:0.353793:0.005330:0.015207:0.000000:0.004349:0.011738:0.013181:0.012508:0.006523:0.012508:0.006315:0.018049:0.003848:0.011738:0.013143:0.006523:0.012508:0.005330:0.013181:0.012508:0.011738:0.013181:0.005792:0.003848:0.006523:0.003848:0.012450:0.005330:0.012450:0.012494:0.003848:0.003848:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792
n:@0.296155:0.382452:0.305917:0.382452:0.305917:0.374012:0.296155:0.374012:0.009762
   Interdigitating dendritic cell sarcoma:@0.305920:0.385571:0.670012:0.385571:0.670012:0.369815:0.305920:0.369815:0.005330:0.015207:0.000000:0.004349:0.011738:0.006523:0.012508:0.005667:0.013181:0.003848:0.012950:0.003848:0.006523:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.013181:0.012508:0.011738:0.013181:0.005792:0.003848:0.006523:0.003848:0.012450:0.005330:0.012450:0.012496:0.003848:0.003848:0.005330:0.007466:0.013143:0.005665:0.012450:0.012604:0.018049:0.013143
n:@0.296155:0.398474:0.305917:0.398474:0.305917:0.390034:0.296155:0.390034:0.009762
   Follicular dendritic cell sarcoma:@0.305920:0.401593:0.621095:0.401593:0.621095:0.385837:0.305920:0.385837:0.005330:0.015207:0.000000:0.009333:0.012604:0.003848:0.003848:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330:0.013181:0.012508:0.011738:0.013181:0.005792:0.003848:0.006523:0.003848:0.012450:0.005330:0.012450:0.012508:0.003848:0.003848:0.005330:0.007466:0.013143:0.005661:0.012450:0.012604:0.018049:0.013143
n:@0.296155:0.414496:0.305917:0.414496:0.305917:0.406056:0.296155:0.406056:0.009762
   Fibroblastic reticular cell tumour:@0.305920:0.417615:0.622015:0.417615:0.622015:0.401859:0.305920:0.401859:0.005330:0.015207:0.000000:0.009333:0.003848:0.013123:0.005719:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.005711:0.012508:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330:0.012450:0.012508:0.003848:0.003848:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792
n:@0.296155:0.430518:0.305917:0.430518:0.305917:0.422078:0.296155:0.422078:0.009762
   Disseminated juvenile xanthogranulomata:@0.305920:0.433637:0.720036:0.433637:0.720036:0.417881:0.305920:0.417881:0.005330:0.015207:0.000000:0.014316:0.003848:0.007466:0.007466:0.012508:0.018049:0.003848:0.011738:0.013143:0.006523:0.012508:0.013181:0.005330:0.003906:0.011699:0.010660:0.012508:0.011738:0.003848:0.003848:0.012508:0.005330:0.009236:0.013143:0.011738:0.006523:0.011738:0.012604:0.012950:0.005792:0.013143:0.011738:0.011699:0.003848:0.012604:0.018049:0.013143:0.006523:0.013143
n:@0.296155:0.446540:0.305917:0.446540:0.305917:0.438100:0.296155:0.438100:0.009762
   Erdheim-Chester disease:@0.305920:0.449659:0.555779:0.449659:0.555779:0.433903:0.305920:0.433903:0.005330:0.015207:0.000000:0.010314:0.005677:0.013181:0.011738:0.012508:0.003848:0.018049:0.006388:0.015644:0.011738:0.012508:0.007466:0.006523:0.012508:0.005792:0.005321:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
Table 1. (cont.):@0.084248:0.087828:0.220676:0.087828:0.220676:0.071795:0.084248:0.071795:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.007120:0.012123:0.012123:0.011353:0.005580:0.005195:0.007312